| Income Statement |
| Total Revenue | 221.43M |
|
| Revenues (USD) | 221.43M |
| Cost of Revenue | 53.64M |
| Gross Profit | 167.78M |
| Operating Expenses | 136.40M |
| Research and Development Expense | 30.71M |
| Selling, General and Administrative Expense | 103.10M |
| Operating Income | 31.38M |
| Interest Expense | 36.43M |
| Income Tax Expense | 3.28M |
| Net Income | -8.26M |
| Net Income Common Stock | -8.26M |
| Net Income Common Stock (USD) | -8.26M |
| Consolidated Income | -8.26M |
| Earning Before Interest & Taxes (EBIT) | 31.44M |
| Earning Before Interest & Taxes (USD) | 31.44M |
| Weighted Average Shares | 81.75M |
| Balance Sheet |
| Cash and Equivalents | 246.47M |
| Cash and Equivalents (USD) | 246.47M |
| Investments | 17.68M |
| Investments Current | 16.57M |
| Investments Non-Current | 1.12M |
| Trade and Non-Trade Receivables | 270.54M |
| Current Assets | 590.85M |
| Property, Plant & Equipment Net | 29.78M |
| Total Assets | 904.79M |
| Debt Current | 54.83M |
| Total Debt | 66.80M |
| Current Liabilities | 699.04M |
| Debt Non-Current | 11.97M |
| Total Liabilities | 857.15M |
| Accumulated Retained Earnings (Deficit) | -590.93M |
| Accumulated Other Comprehensive Income | -34.15M |
| Shareholders Equity | -94.41M |
| Shareholders Equity (USD) | -94.41M |
| Assets Non-Current | 313.94M |
| Total Debt (USD) | 66.80M |
| Deferred Revenue | 38.99M |
| Goodwill and Intangible Assets | 208.88M |
| Liabilities Non-Current | 158.11M |
| Trade and Non-Trade Payables | 517.64M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 12.83M |
| Net Cash Flow from Financing | 15.66M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 27.54M |
| Capital Expenditure | -8.71M |
| Issuance (Repayment) of Debt Securities | 15.65M |
| Net Cash Flow from Investing | -7.67M |
| Net Cash Flow - Investment Acquisitions and Disposals | 1.04M |
| Net Cash Flow from Operations | 29.29M |
| Effect of Exchange Rate Changes on Cash | -9.74M |
| Share Based Compensation | 6.31M |